Challenges of C1-inhibitor concentrate self-administration

International Archives of Allergy and Immunology

Volumn 161, Issue SUPPL.1, 2013, Pages 21-25

  Boysen, H B ^a   Bouillet, L ^b   Aygoren Pursun E ^c  

^a HAEi   (Denmark)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Barriers; Challenges; Hereditary angioedema; Quality of life; Self administration

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR;

ANGIONEUROTIC EDEMA; ARTICLE; DRUG SELF ADMINISTRATION; FOLLOW UP; HUMAN; MENTAL HEALTH; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36; INDEPENDENCE; PATIENT EDUCATION; TIME TO TREATMENT;

ANGIOEDEMAS, HEREDITARY; COMPLEMENT C1 INHIBITOR PROTEIN; HUMANS; QUALITY OF LIFE; SELF ADMINISTRATION;

EID: 84877971864     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000351238     Document Type: Article

References (11)

1. Bygum A, Aygoren-Pursun E, Caballero T, Beusterien K, Gholizadeh S, Musingarimi P, Wait S, Boysen H: The hereditary angioedema burden of illness study in Europe (HAEBOIS- Europe): background and methodology. BMC Dermatol 2012; 12: 4.
2. Lunn ML, Santos CB, Craig TJ: Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients? Ann Allergy Asthma Immunol 2010; 104: 211-214.
3. Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W: Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 2000; 75: 349-354.
4. HAEi International Patient Organization for C1 Inhibitor Deficiencies: State of management of HAE in Europe. 2011. http://www. haeday.org/sites/ default/files/upload/ English%20PDF-%20HAEi-Report.pdf (accessed
5. Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT: The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc 2010; 31: 407-414.
6. Bygum A, Andersen KE, Mikkelsen CS: Selfadministration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Eur J Dermatol 2009; 19: 147-151.
7. Prior N, Remor E, Gomez-Traseira C, Lopez- Serrano C, Cabanas R, Contreras J, Campos A, Cardona V, Cimbollek S, Gonzalez-Quevedo T, Guilarte M, de Rojas DH, Marcos C, Rubio M, Tejedor-Alonso MA, Caballero T: Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project. Health Qual Life Outcomes 2012; 10: 82.
8. Weller K, Groffik A, Magerl M, Tohme N, Martus P, Krause K, Metz M, Staubach P, Maurer M: Development and construct validation of the angioedema quality of life questionnaire. Allergy 2012; 67: 1289-1298.
9. Caballero T, Sala-Cunill A, Cancian M, Craig TJ, Neri S, Keith PK, Boccon-Gibod I, Bethune C, Bork K: Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of HAE. Int Arch Allergy Immunol 2013; 161(suppl 1):10-16.
10. Longhurst HJ, Farkas H, Craig T, Aygoren- Pursun E, Bethune C, Bjorkander J, Bork K, Bouillet L, Boysen H, Bygum A, Caballero T, Cicardi M, Dempster J, Gompels M, Gooi J, Grigoriadou S, Huffer U, Kreuz W, Levi MM, Long J, Martinez-Saguer I, Raguet M, Reshef A, Bowen T, Zuraw B: HAE international home therapy consensus document. Allergy Asthma Clin Immunol 2010; 6: 22.
11. Symons C, Rossi O, Magerl M, Andritschke K: Practical approach to self-administration of intravenous C1-INH concentrate: a nursing perspective. Int Arch Allergy Immunol 2013; 161(suppl 1):17-20.